Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report

DOI: 10.1155/2019/9264824

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text